Header Logo

Connection

SANJAY DESHPANDE to Genetic Markers

Back to Details
This is a "connection" page, showing publications SANJAY DESHPANDE has written about Genetic Markers.
SANJAY DESHPANDE
Connection Strength
0.041
Genetic Markers
  1. Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. Cancer Med. 2022 01; 11(1):61-73.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.